15 years after our first ASH, we return to San Diego to witness the ongoing revolution with bispecific T cell engagers and CAR T cells edging to standard of care status.

Join us at ASCO for the annual gathering with the community, colleagues, and friends shaping the future of oncology treatments and care.

From a European platform to a global event, we have witnessed ESMO's growth into a leading force in oncology.